Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphabet Inc.GOOGL · Entity 2516 | Director | September 14, 2026 | September 17, 2026 |
| GOLDMAN SACHS GROUP INCGS · Entity 2819 | Executive Vice President - CFO | February 07, 2018 | February 09, 2018 |
| RECURSION PHARMACEUTICALS, INC.RXRX · Entity 1008 | Director | April 01, 2024 | April 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphabet Inc.
Report date September 14, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class C Google Stock UnitsSEC Table I · non-derivative | Direct | 597 |
Reported balance
After 2026-09-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 0.4 · Balance 597 F1: The Google Stock Units (GSUs) entitle the Reporting Person to receive one share of Alphabet Inc. Class C Capital Stock for each share underlying the GSU as GSU vests. 1/48 of GSUs vests on the 25th day of each month following the grant date for 31 months and on the 1st day of each month for the following 17 months, subject to continued employment on such vesting dates. F2: Represents the dividend equivalent units (DEUs) that accrued on the Reporting Person's GSUs held as of September 7, 2026, in connection with the cash dividend that was declared by the Issuer and distributed on September 14, 2026. These DEUs will vest on the same schedule as the GSUs on which the DEUs accrued. Each DEU entitles the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the DEU as each DEU vests. F3: Consists of 5 DEUs and 592 GSUs. |
| Class C Google Stock UnitsSEC Table I · non-derivative | Direct | 903 |
Reported balance
After 2026-09-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-14 · Grant · Acquired 1 · Balance 903 F4: 1/4th of GSUs vested on July 25, 2023 and an additional 1/48th of GSUs vests on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates. F2: Represents the dividend equivalent units (DEUs) that accrued on the Reporting Person's GSUs held as of September 7, 2026, in connection with the cash dividend that was declared by the Issuer and distributed on September 14, 2026. These DEUs will vest on the same schedule as the GSUs on which the DEUs accrued. Each DEU entitles the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the DEU as each DEU vests. F5: Consists of 7 DEUs and 896 GSUs. |
| Class C Google Stock UnitsSEC Table I · non-derivative | Direct | 1,433 |
Reported balance
After 2026-09-14 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-14 · Grant · Acquired 1 · Balance 1,433 F6: 1/48 of GSUs will vest on the 25th day of each month following the grant date for 19 months and on the 1st day of each month for the following 29 months, subject to continued service on the Board on the applicable vesting dates. F2: Represents the dividend equivalent units (DEUs) that accrued on the Reporting Person's GSUs held as of September 7, 2026, in connection with the cash dividend that was declared by the Issuer and distributed on September 14, 2026. These DEUs will vest on the same schedule as the GSUs on which the DEUs accrued. Each DEU entitles the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the DEU as each DEU vests. F7: Consists of 5 DEUs and 1,428 GSUs. |
| Class C Google Stock UnitsSEC Table I · non-derivative | Direct | 941 |
Reported balance
After 2026-09-14 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-09-14 · Grant · Acquired 1 · Balance 941 F8: 1/48 of GSUs shall vest on the 25th of the month of the Grant Date, vesting 1/48 every 1 month(s) for 7 event(s); 1/48 of GSUs shall vest on the 1st of the month 7 month(s) after the Grant Date, vesting 1/48 every 1 month(s) for 41 event(s), subject to continued employment on such vesting date(s). F2: Represents the dividend equivalent units (DEUs) that accrued on the Reporting Person's GSUs held as of September 7, 2026, in connection with the cash dividend that was declared by the Issuer and distributed on September 14, 2026. These DEUs will vest on the same schedule as the GSUs on which the DEUs accrued. Each DEU entitles the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the DEU as each DEU vests. F9: Consists of 1 DEU and 940 GSUs. |
| Class C Capital StockSEC Table I · non-derivative | Direct | 9,989 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 9,989 |
Filing footnotes · ownership attribution and instrument terms
F1: The Google Stock Units (GSUs) entitle the Reporting Person to receive one share of Alphabet Inc. Class C Capital Stock for each share underlying the GSU as GSU vests. 1/48 of GSUs vests on the 25th day of each month following the grant date for 31 months and on the 1st day of each month for the following 17 months, subject to continued employment on such vesting dates.
F2: Represents the dividend equivalent units (DEUs) that accrued on the Reporting Person's GSUs held as of September 7, 2026, in connection with the cash dividend that was declared by the Issuer and distributed on September 14, 2026. These DEUs will vest on the same schedule as the GSUs on which the DEUs accrued. Each DEU entitles the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the DEU as each DEU vests.
F3: Consists of 5 DEUs and 592 GSUs.
F4: 1/4th of GSUs vested on July 25, 2023 and an additional 1/48th of GSUs vests on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates.
F5: Consists of 7 DEUs and 896 GSUs.
F6: 1/48 of GSUs will vest on the 25th day of each month following the grant date for 19 months and on the 1st day of each month for the following 29 months, subject to continued service on the Board on the applicable vesting dates.
F7: Consists of 5 DEUs and 1,428 GSUs.
F8: 1/48 of GSUs shall vest on the 25th of the month of the Grant Date, vesting 1/48 every 1 month(s) for 7 event(s); 1/48 of GSUs shall vest on the 1st of the month 7 month(s) after the Grant Date, vesting 1/48 every 1 month(s) for 41 event(s), subject to continued employment on such vesting date(s).
F9: Consists of 1 DEU and 940 GSUs.
GOLDMAN SACHS GROUP INC
Report date February 07, 2018 · Filed February 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 76,829 |
Ending reported balance
After 2018-02-07 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-02-07 · Sale · Disposed 1,575 · Balance 85,543 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F2: Reflects a weighted average sale price of $257.4576 per share, at prices ranging from $256.90 and $257.85 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2018-02-07 · Sale · Disposed 1,800 · Balance 83,743 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F3: Reflects a weighted average sale price of $258.3761 per share, at prices ranging from $257.90 and $258.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2018-02-07 · Sale · Disposed 3,958 · Balance 79,785 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F4: Reflects a weighted average sale price of $259.4384 per share, at prices ranging from $258.98 and $259.96 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2018-02-07 · Sale · Disposed 2,656 · Balance 77,129 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F5: Reflects a weighted average sale price of $260.4378 per share, at prices ranging from $260.00 and $260.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 5 · 2018-02-07 · Sale · Disposed 300 · Balance 76,829 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F6: Reflects a weighted average sale price of $261.27 per share, at prices ranging from $261.06 and $261.44 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee footnote | 0 |
Last balance in matching sequence
After 2018-02-07 transaction · row 8
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 6 · 2018-02-07 · Sale · Disposed 540 · Balance 1,000 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F7: Reflects a weighted average sale price of $257.3872 per share, at prices ranging from $257.02 and $257.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Row 7 · 2018-02-07 · Sale · Disposed 500 · Balance 500 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F8: Reflects a weighted average sale price of $259.264 per share, at prices ranging from $258.86 and $259.63 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Row 8 · 2018-02-07 · Sale · Disposed 500 · Balance 0 F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F9: Reflects a weighted average sale price of $260.432 per share, at prices ranging from $260.11 and $260.75 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person.
F2: Reflects a weighted average sale price of $257.4576 per share, at prices ranging from $256.90 and $257.85 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects a weighted average sale price of $258.3761 per share, at prices ranging from $257.90 and $258.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: Reflects a weighted average sale price of $259.4384 per share, at prices ranging from $258.98 and $259.96 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5: Reflects a weighted average sale price of $260.4378 per share, at prices ranging from $260.00 and $260.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6: Reflects a weighted average sale price of $261.27 per share, at prices ranging from $261.06 and $261.44 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7: Reflects a weighted average sale price of $257.3872 per share, at prices ranging from $257.02 and $257.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8: Reflects a weighted average sale price of $259.264 per share, at prices ranging from $258.86 and $259.63 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9: Reflects a weighted average sale price of $260.432 per share, at prices ranging from $260.11 and $260.75 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F10: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares.
RECURSION PHARMACEUTICALS, INC.
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 60,078 |
Reported balance
After 2024-04-01 transaction · row 1
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 2,001 · Balance 60,078 F1: Shares were issued pursuant to Issuer's Outside Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were issued pursuant to Issuer's Outside Director Compensation Policy.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2022 Filed Jul 6, 2022 21:49 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041279 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,476 F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. Read SEC document |
| June 14, 2022 Filed Jun 17, 2022 00:10 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantStock Option (right to buy) · Derivative | 36,290 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001209191-22-037629 · doc4.xml · derivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,290 Underlying: Class A Common Stock · 36,290 shares Expires 2032-06-14 Read SEC document |
| June 14, 2022 Filed Jun 17, 2022 00:10 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 18,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037629 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,252 F1 · shares: Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 14, 2023 or the day prior to the Issuer's 2023 annual meeting of stockholders. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:22 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 2,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023308 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,107 F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002053 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,669 F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:35 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 858 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059748 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,629 F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. F1 · price: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:00 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantClass A Common Stock | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045553 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,771 F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. F1 · price: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionStock Option (Right to Buy) · Derivative | 525,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · derivative · entry 6 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,000 Underlying: Class A Common Stock · 525,000 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the award shall vest one month after April 23, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. F2 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionStock Option (Right to Buy) · Derivative | 525,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · derivative · entry 5 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 525,000 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the award shall vest one month after April 23, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. F2 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · derivative · entry 4 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Class A Common Stock · 12,500 shares Expires 2031-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders. F2 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · derivative · entry 3 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2031-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders. F2 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionClass A Common Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · nonDerivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders. F2 · price: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 23:43 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | ConversionCommon Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-028022 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders. F2 · price: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 23:25 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027398 · doc4.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · security: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. F2 · shares: The shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 23:25 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027398 · doc4.xml · derivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2031-04-14 F3 · derivative.exercise_date: The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders. F1 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 500 | $260.43 | $130,216.00 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 8 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F9 · price: Reflects a weighted average sale price of $260.432 per share, at prices ranging from $260.11 and $260.75 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 500 | $259.26 | $129,632.00 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 7 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 500 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F8 · price: Reflects a weighted average sale price of $259.264 per share, at prices ranging from $258.86 and $259.63 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 540 | $257.39 | $138,989.09 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 6 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F7 · price: Reflects a weighted average sale price of $257.3872 per share, at prices ranging from $257.02 and $257.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F10 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 300 | $261.27 | $78,381.00 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 5 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,829 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F6 · price: Reflects a weighted average sale price of $261.27 per share, at prices ranging from $261.06 and $261.44 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 2,656 | $260.44 | $691,722.80 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 4 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,129 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F5 · price: Reflects a weighted average sale price of $260.4378 per share, at prices ranging from $260.00 and $260.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 3,958 | $259.44 | $1,026,857.19 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 3 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,785 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F4 · price: Reflects a weighted average sale price of $259.4384 per share, at prices ranging from $258.98 and $259.96 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 1,800 | $258.38 | $465,076.98 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,743 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F3 · price: Reflects a weighted average sale price of $258.3761 per share, at prices ranging from $257.90 and $258.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 19:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 1,575 | $257.46 | $405,495.72 |
DisclosureSEC source: 0000769993-18-000209 · ownershipdoc02062018032830.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,543 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F2 · price: Reflects a weighted average sale price of $257.4576 per share, at prices ranging from $256.90 and $257.85 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 800 | $269.53 | $215,624.00 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 7 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,540 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F8 · price: Reflects a weighted average sale price of $269.53 per share, at prices ranging from $269.04 and $269.95 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F9 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 540 | $268.45 | $144,962.19 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 6 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,340 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F7 · price: Reflects a weighted average sale price of $268.4485 per share, at prices ranging from $268.01 and $268.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F9 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 200 | $266.96 | $53,392.00 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 5 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,880 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F6 · price: Reflects a weighted average sale price of $266.96 per share, at prices ranging from $266.89 and $267.03 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F9 · ownership.nature: Held through a trust, the sole trustee of which is the Reporting Person's spouse and the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 3,164 | $269.72 | $853,389.65 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 4 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,118 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F5 · price: Reflects a weighted average sale price of $269.7186 per share, at prices ranging from $269.46 and $269.98 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 3,474 | $268.92 | $934,210.71 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 3 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,282 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F4 · price: Reflects a weighted average sale price of $268.915 per share, at prices ranging from $268.45 and $269.40 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 2,108 | $268.14 | $565,243.55 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,756 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F3 · price: Reflects a weighted average sale price of $268.1421 per share, at prices ranging from $267.44 and $268.41 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:00 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | SaleCommon Stock, par value $0.01 per share | 1,543 | $267.01 | $412,003.99 |
DisclosureSEC source: 0000769993-18-000154 · ownershipdoc01292018065120.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,864 F1 · kind: This transaction was automatically triggered pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person, without any additional action taken by the Reporting Person. F2 · price: Reflects a weighted average sale price of $267.0149 per share, at prices ranging from $266.43 and $267.41 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 28, 2017 Filed Dec 29, 2017 11:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | Exercise / conversionRestricted Stock Units · Derivative | 58,108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000769993-17-000791 · ownershipdoc12262017044029.xml · derivative · entry 4 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 58,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On December 28, 2017, shares of the Issuer's common stock underlying Restricted Stock Units ("RSUs") that were awarded in connection with compensation for years prior to 2017 were delivered to the Reporting Person without the payment of any consideration. These shares are not related to 2017 compensation. The shares were scheduled to be delivered in January 2018; however, the Board of Directors of the Issuer, in its sole discretion, determined to make this delivery in December 2017 due to changes in U.S. tax law and the associated tax savings to the Issuer that resulted from making the delivery prior to year-end. F1 · price: On December 28, 2017, shares of the Issuer's common stock underlying Restricted Stock Units ("RSUs") that were awarded in connection with compensation for years prior to 2017 were delivered to the Reporting Person without the payment of any consideration. These shares are not related to 2017 compensation. The shares were scheduled to be delivered in January 2018; however, the Board of Directors of the Issuer, in its sole discretion, determined to make this delivery in December 2017 due to changes in U.S. tax law and the associated tax savings to the Issuer that resulted from making the delivery prior to year-end. F1 · derivative.exercise_date: On December 28, 2017, shares of the Issuer's common stock underlying Restricted Stock Units ("RSUs") that were awarded in connection with compensation for years prior to 2017 were delivered to the Reporting Person without the payment of any consideration. These shares are not related to 2017 compensation. The shares were scheduled to be delivered in January 2018; however, the Board of Directors of the Issuer, in its sole discretion, determined to make this delivery in December 2017 due to changes in U.S. tax law and the associated tax savings to the Issuer that resulted from making the delivery prior to year-end. F1 · derivative.expiration_date: On December 28, 2017, shares of the Issuer's common stock underlying Restricted Stock Units ("RSUs") that were awarded in connection with compensation for years prior to 2017 were delivered to the Reporting Person without the payment of any consideration. These shares are not related to 2017 compensation. The shares were scheduled to be delivered in January 2018; however, the Board of Directors of the Issuer, in its sole discretion, determined to make this delivery in December 2017 due to changes in U.S. tax law and the associated tax savings to the Issuer that resulted from making the delivery prior to year-end. Read SEC document |
| December 28, 2017 Filed Dec 29, 2017 11:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | Tax withholdingCommon Stock, par value $0.01 per share | 32,435 | $255.95 | $8,301,738.25 |
DisclosureSEC source: 0000769993-17-000791 · ownershipdoc12262017044029.xml · nonDerivative · entry 2 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,407 F2 · kind: Represents shares of the Issuer's common stock withheld to satisfy withholding obligations in connection with the delivery of the common stock underlying the RSUs described in footnote 1 above. F2 · acquired: Represents shares of the Issuer's common stock withheld to satisfy withholding obligations in connection with the delivery of the common stock underlying the RSUs described in footnote 1 above. Read SEC document |
| December 28, 2017 Filed Dec 29, 2017 11:01 UTC | GOLDMAN SACHS GROUP INC GS · Entity 2819 | Exercise / conversionCommon Stock, par value $0.01 per share | 58,108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000769993-17-000791 · ownershipdoc12262017044029.xml · nonDerivative · entry 1 CHAVEZ R. MARTIN · CIK 0001157983 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On December 28, 2017, shares of the Issuer's common stock underlying Restricted Stock Units ("RSUs") that were awarded in connection with compensation for years prior to 2017 were delivered to the Reporting Person without the payment of any consideration. These shares are not related to 2017 compensation. The shares were scheduled to be delivered in January 2018; however, the Board of Directors of the Issuer, in its sole discretion, determined to make this delivery in December 2017 due to changes in U.S. tax law and the associated tax savings to the Issuer that resulted from making the delivery prior to year-end. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.